Collegium Pharmaceutical (COLL) Institutional Ownership

Of the 231 institutional investors that purchased Collegium Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.19M), Pacer Advisors Inc. ($821.54K), Massachusetts Financial Services Co. MA ($744.70K), Assenagon Asset Management S.A. ($700.29K), Rubric Capital Management LP ($657.22K), Millennium Management LLC ($624.39K), and Marshall Wace LLP ($563.32K).

Institutional investors have bought a total of 7,365,279 shares in the last 24 months. This purchase volume represents approximately $283.27M in transactions.

Of the 110 institutional investors that sold Collegium Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Citigroup Inc. ($3.41M), Rubric Capital Management LP ($1.88M), Jump Financial LLC ($1.52M), Eventide Asset Management LLC ($765.16K), Invesco Ltd. ($457.30K), Emerald Advisers LLC ($424.45K), and Bank of America Corp DE ($269.04K).

Institutional investors have sold a total of 11,395,703 shares in the last 24 months. This volume of shares sold represents approximately $444.69M in transactions.